On September 11, 2024, Conley Chee, President & CEO of Syros Pharmaceuticals Inc (SYRS, Financial), purchased 100,000 shares of the company, as reported in a recent SEC Filing. Following this transaction, the insider now owns a total of 122,504 shares.
Syros Pharmaceuticals Inc is engaged in the development of medicines that control the expression of genes to treat cancer and other diseases. This recent purchase by the insider is part of a broader trend observed over the past year, where there have been three insider buys and four insider sells within the company.
On the date of the purchase, shares of Syros Pharmaceuticals Inc were priced at $1.61, leading to a market cap of approximately $42.094 million. According to GF Value, the stock is currently significantly overvalued, with a price-to-GF-Value ratio of 2.93. The GF Value is calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, adjusted for the company’s past performance and expected future business outcomes.
Insider transactions can provide valuable insights into a company's financial health and management's perspective on the stock's valuation. This recent acquisition by the insider might indicate a positive outlook on the company's future performance despite the current market valuation.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
